Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

AG Edwards Cuts Cyberonics to Sell

AG Edwards cut Cyberonics (CYBX) to sell.

Analyst Jan David Wald says the company's growth prospects were predicated upon approval of a VNS device for depression, and the FDA's rejection is a large blow. He says the FDA found that some depression patients were worse off utilizing the device than before.

Wald thinks the FDA didn't want to set a precedent for devices with questionable statistics and data, and therefore rejected it. He believes this setback could push Cyberonics back until 2008 for FDA approval, provided it continues with the device.

Wald sees a 73-cent fiscal 2005 (Apr.) loss.

blog comments powered by Disqus